Linguagen Corp., a biotechnology firm based in New Jersey, has developed and patented a family of compounds that can block the taste of bitter medicines and foods, New Scientist reported last week. The “bitter blockers” work by blocking the production of a protein called gustducin, which is released by taste-receptor cells in the mouth when they detect a bitter substance. Gustducin sparks a series of reactions that results in a nerve impulse to the brain signaling a bitter taste. The researchers aren’t exactly sure how the blockers work, but think that the compounds bond to the mouth’s bitter-taste receptors, inhibiting gustducin’s release. If Linguagen’s blockers prove to be safe and effective, they could make drugs and bitter-flavored foods such as broccoli and grapefruit more palatable, as well as reduce the huge amounts of fat, salt, and sugar needed to mask the bitter taste of processed foods.
-
Recent Posts
Archives
- September 2022
- August 2020
- June 2019
- August 2017
- August 2016
- December 2015
- October 2015
- February 2015
- June 2014
- January 2014
- July 2013
- February 2013
- January 2013
- August 2012
- January 2012
- August 2011
- January 2011
- August 2010
- May 2010
- April 2010
- October 2009
- January 2009
- May 2008
- April 2008
- January 2008
- September 2007
- March 2006
- February 2006
- January 2006
- November 2005
- October 2005
- September 2005
- May 2005
- April 2005
- January 2005
- November 2004
- September 2004
- July 2004
- June 2004
- May 2004
- April 2004
- March 2004
- February 2004
- January 2004
- December 2003
- November 2003
- October 2003
- September 2003
- August 2003
- July 2003
- June 2003
- May 2003
- April 2003
- March 2003
- February 2003
- January 2003
- November 2002
Categories
Meta